BIT
INO icon

BlackRock Institutional Trust’s Inovio Pharmaceuticals INO Stock Holding History

BlackRock Institutional Trust’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$12.8M Buy
153,155
+383
+0.3% +$34.6K ﹤0.01% 2259
2016
Q3 		$17.1M Buy
152,772
+1,495
+1% +$165K ﹤0.01% 1997
2016
Q2 		$16.8M Sell
151,277
-4,300
-3% -$522K ﹤0.01% 1957
2016
Q1 		$16.3M Sell
155,577
-137
-0.1% -$10.6K ﹤0.01% 1955
2015
Q4 		$12.6M Buy
155,714
+19,873
+15% +$1.58M ﹤0.01% 2180
2015
Q3 		$9.42M Buy
135,841
+9,237
+7% +$805K ﹤0.01% 2334
2015
Q2 		$12.4M Buy
126,604
+21,697
+21% +$2.32M ﹤0.01% 2264
2015
Q1 		$10.3M Buy
104,907
+28,048
+36% +$2.72M ﹤0.01% 2381
2014
Q4 		$8.47M Buy
76,859
+21,821
+40% +$2.67M ﹤0.01% 2457
2014
Q3 		$6.5M Sell
55,038
-4,709
-8% -$587K ﹤0.01% 2559
2014
Q2 		$7.75M Buy
59,747
+52,907
+773% +$6.24M ﹤0.01% 2568
2014
Q1 		$1.09M Buy
6,840
+3,333
+95% +$478K ﹤0.01% 3388
2013
Q4 		$488K Buy
3,507
+169
+5% +$16.9K ﹤0.01% 3580
2013
Q3 		$332K Buy
+3,338
New +$280K ﹤0.01% 3596

Other funds holding INO

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Institutional Trust's INO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Inovio Pharmaceuticals (INO) stake by 0.25% in Q4 2016, buying an estimated $34.6K and bringing the position to 153,155 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2259.

BlackRock Institutional Trust first reported a position in INO in Q3 2013 and has held it in 14 quarters since. The position peaked at $17.1M in Q3 2016. 125 funds tracked by Wall St. Rank hold INO as of Q4 2016.

  • BlackRock Institutional Trust held 153,155 shares of Inovio Pharmaceuticals worth $12.8M as of Q4 2016.
  • BlackRock Institutional Trust bought 383 Inovio Pharmaceuticals shares in Q4 2016, an estimated $34.6K.
  • Inovio Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2259 holding.
  • BlackRock Institutional Trust first reported a position in Inovio Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Institutional Trust's Inovio Pharmaceuticals position peaked at $17.1M in Q3 2016.
  • 125 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.